Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Poumon, type non à petites cellules
- | Specialty :
- Chimiothérapie
- Thérapies Ciblées
Extract
A randomized, double blind study to determine the effect of two dose schedules of R1507 or placebo, both in combination with Tarceva (erlotinib), on progression-free survival in patients with advanced non-small cell lung cancer with disease progression after first or second line therapy.
Scientific Abstract
en cours d'intégration;